Nelson Lab Research

Research Overview
The Nelson Lab focuses on characterizing and improving patient outcomes for traumatic brain injury, or TBI. Using a variety of quantitative—and sometimes qualitative— methods, the Nelson Lab investigates a diverse ranges of TBI-related problems, posing questions such as:
- What is the typical course of TBI recovery from the immediate post-injury period onward, such as the areas of subjective symptoms, observable clinical signs, cognitive performance, and day-to-day functioning?
- What are the subtypes of TBI that might inform more precision medicine approaches to treatment?
- How and why do patients differ in their TBI outcomes?
- How can measures of TBI-related disability be made more sensitive to better reflect treatment effects in clinical trials?
- What improvements to clinical care would patients with TBI and their families value?
- How can healthcare systems better adopt evidence-based practices and improve care pathways for persons with TBI?
Active Research Projects
Active research projects in the Nelson Lab include phenotyping traumatic brain injury, improving outcome measurement for clinical trials, understanding individual differences in TBI recovery and outcomes, as well as developing patient-centered systems for care for TBI.

Phenotyping Traumatic Brain Injury
TBI is a heterogeneous injury that affects patients in diverse ways. The Nelson Lab uses latent variable modeling strategies such as factor analysis and latent profile analysis with large, multicenter samples of athletes and community members with TBI to understand heterogeneity in how patients present after TBI, with goals of identifying subtypes of injury that may inform more personalized assessment and treatment approaches.
Representative Publications
- Modeling the structure of acute sport-related concussion symptoms: A bifactor approach
- Latent profile analysis of neuropsychiatric symptoms and cognitive function of adults 2 weeks after traumatic brain injury: Findings from the TRACK-TBI study
- Neurobehavioral traits as transdiagnostic predictors of clinical problems
Images
Top: Example of a factor model showing how one can conceptualize and estimate latent dimensions of Somatic, Cognitive, and Affective symptoms by modeling the correlations among 9 observed symptom ratings. The dimensions of Somatic, Cognitive, and Affective symptoms are subsumed by a common factor that explains their correlations.
Bottom: A hypothetical latent class model showing how a sample who has rated themselves on Somatic, Cognitive, and Affective symptom dimensions could be stratified into 5 qualitatively distinct subgroups, who differ in their symptom profile. In this example the symptom profiles are Low symptoms, High symptoms, and Somatic, Cognitive, or Affective symptoms only.
Improving Outcome Measurements for Clinical Trials

Expert's believe the field's long history of unsuccessful clinical trials is, in part, a result of its use of an outcome measure that is not sufficiently sensitive to individual differences in TBI-related disability and recovery. Investigators at the Nelson Lab use Item Response Theory (IRT) and other psychometric tools to understand and improve clinical outcome measures, such as measures of TBI-related symptoms, functional limitations, quality of life, and cognitive performance. Goals of this work are to produce clinical trial endpoints that are better able to detect treatment effects; more accurately reflect patients' experiences of TBI; and improve evidence-based personalized outcome measurement strategies for clinical and translational studies of TBI.
Representative Publications
- Validating multidimensional outcome assessment using the TBI Common Data Elements: An analysis of the TRACK-TBI Pilot sample
- Validity of the Brief Test of Adult Cognition by Telephone (BTACT) in Level 1 trauma center patients 6 months post traumatic brain injury: A TRACK-TBI study
- Functional Status Examination yields higher measurement precision than the Glasgow Outcome Scale-Extended after moderate-to-severe traumatic brain injury
- Improving the precision of the Glasgow Outcome Scale-Extended using item response theory: A TRACK-TBI study
Image
Figure compares the measurement precision of 3 traumatic brain injury disability outcome measures. The x-axis reflects estimated disability level, as modeled by an item response theory model. The y-axis displays the test information of each of the 3 outcome measures. The measure with the lowest information is the Glasgow Outcome Scale Extended (GOSE), a conventional outcome measure treated as an ordinal 8-level variable. The measure with the next highest information is the GOSE rescored using item response theory. The measure with the highest information is the Functional Status Examination, another measure of injury-related disability.
Understanding Individual Differences in Traumatic Brain Injury Recovery and Outcomes
Improving personalized medicine for TBI will require better understanding why individuals have such different outcomes from what appear to be similar injuries. We investigate how diverse neurobiological, psychosocial, and environmental factors influence acute presentation and outcome from TBI, which will inform ongoing efforts to build systems of care for TBI that address our patients' needs.
Representative Publications
- Acute clinical predictors of symptom recovery in emergency department patients with mild traumatic brain injury and non-traumatic brain injuries
- Recovery following mild traumatic brain injury in patients presenting to U.S. Level 1 trauma centers: A TRACK-TBI study
- Relationship between neighborhood disadvantage and mild traumatic brain injury symptoms
- Functional recovery, symptoms, and quality of life 1–5 years after traumatic brain injury: A TRACK-TBI study
Image
Figure displays a circular puzzle with 4 quadrants. The top left quadrant conveys pre-injury risk and resilience factors such as genetics, neurophysiology, social determinants, cognitive reserve, psychiatric symptoms, and personality traits. The bottom left quadrant conveys injury characteristics such as cause of injury, TBI characteristics, polytrauma, and complications. The bottom right quadrant conveys environment, exemplified by treatment and rehabilitation, social support, financial resources, secondary gain, and repeated trauma exposure. The top left quadrant conveys injury response, exemplified by symptoms, attributions/expectancies, cognitive sequelae, neurophysiologic response, and epigenetics.
Developing Patient-Centered Systems for Care for Traumatic Brain Injury
There is a great need for the development of standardized, coordinated systems of care for persons with TBI around the globe. The Nelson Lab's ongoing projects—led by a multi-stakeholder group of persons with TBI, clinicians, hospital administrators, researchers, and others—is performing mixed-methods research, quality improvement initiatives, and implementation science studies to build better healthcare systems for community members with TBI.
Image
Figure displays a pie chart with 3 segments—patient feedback, stakeholder engagement, and clinical improvements. Arrows linking the segments convey that they inform each other.
Recent Publications
-
(Eagle SR, Temkin N, Barber JK, McCrea M, Giacino JT, Okonkwo D, Manley GT, Nelson L, TRACK-TBI Investigators.) Neurology. 2025 Apr 22;104(8):e213427 PMID: 40168631 PMCID: PMC11966525 SCOPUS ID: 2-s2.0-105002821584 04/01/2025
-
(Simons MU, Maio A, Huber DL, Corrigan JD, Temkin N, Darsie M, Kitagawa R, Whyte J, Giacino JT, Stein MB, Manley GT, McCrea MA, Nelson LD.) J Neurotrauma. 2025 Apr 09 PMID: 40200896 SCOPUS ID: 2-s2.0-105003876398 04/09/2025
-
(Temkin N, Barber J, Machamer J, Sugar G, Morrissey MR, Boase K, Zahniser E, Bodien YG, Giacino JT, McCrea MA, Nelson LD, Stein MB, Taylor S, Robertson C, Okonkwo D, Manley G, Dikmen S, TRACK-TBI Investigators.) J Neurotrauma. 2025 Apr 09 PMID: 40200868 SCOPUS ID: 2-s2.0-105003882256 04/09/2025
-
Outcomes after Traumatic Brain Injury with and Without Computed Tomography.
(Mikolić A, Shi S, Panenka W, Brubacher JR, Scheuermeyer FX, Nelson LD, Silverberg ND.) J Neurotrauma. 2025 Mar;42(5-6):391-398 PMID: 39470625 SCOPUS ID: 2-s2.0-85208240995 10/29/2024
-
(Harris M, Yue JK, Jain S, Sun X, Puccio AM, Gardner RC, Wang KKW, Okonkwo DO, Yuh EL, Mukherjee P, Nelson LD, Taylor SR, Markowitz AJ, Diaz-Arrastia R, Manley GT, Korley FK, TRACK‐TBI Investigators.) Acad Emerg Med. 2025 Feb 18 PMID: 39967286 SCOPUS ID: 2-s2.0-85219212820 02/19/2025
-
(Eagle SR, Zynda AJ, Sandulli L, Hickey RW, Kegel NE, Nelson L, McCrea M, Collins MW, Okonkwo DO, Thomas DG, Kontos AP.) J Pediatr. 2025 Feb;277:114386 PMID: 39489284 SCOPUS ID: 2-s2.0-85210073576 11/04/2024
-
(Eagle SR, Gardner RC, Jain S, Sun X, Puccio A, Brent D, Nelson LD, McCrea MA, Giacino JT, Okonkwo DO, Yue JK, Manley GT, Stein MB, TRACK-TBI Investigators .) Brain Commun. 2025;7(2):fcaf123 PMID: 40190352 PMCID: PMC11968334 SCOPUS ID: 2-s2.0-105002234323 04/07/2025
-
(Eagle SR, Barber J, Temkin N, McCrea MA, Giacino JT, Okonkwo DO, Madhok D, Yue JK, Zerbato JM, Manley GT, Nelson LD, Keene CD, Krishnamoorthy V, Mac Donald C, Merchant R, Mukherjee P, Ngwenya LB, Puccio A, Robertson C, Rodgers RB, Taylor SR, Zafonte R.) Frontiers in Neurology. 2025;16 SCOPUS ID: 2-s2.0-105003374076 01/01/2025
-
(Martinez KA, Ryu E, Patrick CJ, Temkin NR, Stein MB, Magnus BE, McCrea MA, Manley GT, Nelson LD, TRACK-TBI Investigators.) Psychol Med. 2024 Aug;54(11):3089-3098 PMID: 39228231 SCOPUS ID: 2-s2.0-85203120679 09/04/2024
-
(Simons MU, Magnus BE, Nelson LD, Nitta ME, Hoelzle JB.) Journal of Psychopathology and Behavioral Assessment. December 2024;46(4):1000-1008 SCOPUS ID: 2-s2.0-85205113474 12/01/2024
-
(Kals M, Wilson L, Levey DF, Parodi L, Steyerberg EW, Richardson S, He F, Sun X, Jain S, Palotie A, Ripatti S, Rosand J, Manley GT, Maas AIR, Stein MB, Menon DK, Ackerlund C, Adams H, Amrein K, Andelic N, Andreassen L, Anke A, Antoni A, Audibert G, Azouvi P, Azzolini ML, Bartels R, Barzó P, Beauvais R, Beer R, Bellander BM, Belli A, Benali H, Berardino M, Beretta L, Blaabjerg M, Bragge P, Brazinova A, Brinck V, Brooker J, Brorsson C, Buki A, Bullinger M, Cabeleira M, Caccioppola A, Calappi E, Calvi MR, Cameron P, Lozano GC, Carbonara M, Castaño-León AM, Cavallo S, Chevallard G, Chieregato A, Citerio G, Clusmann H, Coburn MS, Coles J, Cooper JD, Correia M, Čović A, Curry N, Czeiter E, Czosnyka M, Dahyot-Fizelier C, Dark P, Dawes H, De Keyser V, Degos V, Della Corte F, Boogert Hd, Depreitere B, Đilvesi Đ, Dixit A, Donoghue E, Dreier J, Dulière GL, Ercole A, Esser P, Ezer E, Fabricius M, Feigin VL, Foks K, Frisvold S, Furmanov A, Gagliardo P, Galanaud D, Gantner D, Gao G, George P, Ghuysen A, Giga L, Glocker B, Golubović J, Gomez PA, Gratz J, Gravesteijn B, Grossi F, Gruen RL, Gupta D.) eClinicalMedicine. December 2024;78 SCOPUS ID: 2-s2.0-85211046835 12/01/2024
-
(Yue JK, Kanter JH, Barber JK, Huang MC, van Essen TA, Elguindy MM, Foreman B, Korley FK, Belton PJ, Pisică D, Lee YM, Kitagawa RS, Vassar MJ, Sun X, Satris GG, Wong JC, Ferguson AR, Huie JR, Wang KKW, Deng H, Wang VY, Bodien YG, Taylor SR, Madhok DY, McCrea MA, Ngwenya LB, DiGiorgio AM, Tarapore PE, Stein MB, Puccio AM, Giacino JT, Diaz-Arrastia R, Lingsma HF, Mukherjee P, Yuh EL, Robertson CS, Menon DK, Maas AIR, Markowitz AJ, Jain S, Okonkwo DO, Temkin NR, Manley GT, Chung JE, Coskun B, Eagle SR, Etemad LL, Fabian B, Ramana FV, Gopinath S, Gotthardt CJ, Grandhi R, Hamidi S, Jha RM, Madden C, Merchant R, Nelson LD, Rodgers RB, Schneider ALC, Schnyer DM, Torres-Espin A, Tracey JX, Valadka AB, Zafonte RD.) The Lancet Regional Health - Americas. November 2024;39 SCOPUS ID: 2-s2.0-85206516113 11/01/2024